Abstract
The purpose of this work was to evaluate CMR T1 and T2 mapping sequences in patients with intracardiac thrombi and masses in order to assess T1 and T2 relaxometry usefulness and to allow better etiological diagnosis. This observational study of patients scheduled for routine CMR was performed from September 2014 to August 2015. All patients referred to our department for a 1.5 T CMR were screened to participate. T1 mapping were acquired before and after Gadolinium injection; T2 mapping images were obtained before injection. 41 patients were included. 22 presented with cardiac thrombi and 19 with cardiac masses. The native T1 of thrombi was 1037 ± 152 ms (vs 1032 ± 39 ms for myocardium, p = 0.88; vs 1565 ± 88 ms for blood pool, p < 0.0001). T2 were 74 ± 13 ms (vs 51 ± 3 ms for myocardium, p < 0.0001; vs 170 ± 32 ms for blood pool, p < 0.0001). Recent thrombi had a native T1 shorter than old thrombi (911 ± 177 vs 1169 ± 107 ms, p = 0.01). The masses having a shorter T1 than the myocardium were lipomas (278 ± 29 ms), calcifications (621 ± 218 ms), and melanoma (736 ms). All other masses showed T1 values higher than myocardial T1, with T2 consistently >70 ms. T1 and T2 mapping CMR sequences can be useful and represent a new approach for the evaluation of cardiac thrombi and masses.
Similar content being viewed by others
Abbreviations
- CMR:
-
Cardiac magnetic resonance
- HASTE:
-
Half-Fourier acquisition single-shot turbo spin-echo
- LGE:
-
Late gadolinium enhancement
- MRI:
-
Magnetic resonance imaging
- MOLLI:
-
Modified Look-Locker inversion-recovery
- ROI:
-
Region of interest
- SSFP:
-
Steady-state free precession
- STIR:
-
Short Tau-inversion recovery
- Tx mapping:
-
T1 and T2 mapping software
References
Sütsch G, Jenni R, von Segesser L, Schneider J (1991) Heart tumors: incidence, distribution, diagnosis—exemplified by 20,305 echocardiographies. Schweiz Med Wochenschr 121:621–629
Mollet NR, Dymarkowski S, Volders W et al (2002) Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 106:2873–2876
Motwani M, Kidambi A, Herzog BA, Uddin A, Greenwood JP, Plein S (2013) MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology 268:26–43
Salerno M, Kramer CM (2013) Advances in parametric mapping with CMR imaging. J Am Coll Cardiovasc Imaging 6:806–822
Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146
Germain P, El Ghannudi S, Jeung M-Y et al (2014) Native T1 mapping of the heart—a pictorial review. Clin Med Insights Cardiol 8:1–11
Kübler D, Gräfe M, Schnackenburg B (2013) T1 and T2 mapping for tissue characterization of cardiac myxoma. Int J Cardiol 169:e17–e20
Ferreira VM, Holloway CJ, Piechnik SK, Karamitsos TD, Neubauer S (2013) Is it really fat? Ask a T1-map. Eur Heart J Cardiovasc Imaging 14:1060
Blackmore CC, Francis CW, Bryant RG, Brenner B, Marder VJ (1990) Magnetic resonance imaging of blood and clots in vitro. Invest Radiol 25:1316–1324
Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S (2005) Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 h and treated with recombinant tissue plasminogen activator. Am J Neuroradiol 26:618–624
Corti R, Osende JI, Fayad ZA et al (2002) In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol 39:1366–1373
Esposito A, De Cobelli F, Ironi G (2014) CMR in assessment of cardiac masses: primary benign tumors. J Am Coll Cardiol Imaging 7:733–736
Braggion-Santos MF, Koenigkam-Santos M, Teixeira SR, Volpe GJ, Trad HS, Schmidt A (2013) Magnetic resonance imaging evaluation of cardiac masses. Arq Bras Cardiol 101(3):263–272
Altbach MI, Squire SW, Kudithipudi V, Castellano L, Sorrell VL (2007) Cardiac MRI is complementary to echocardiography in the assessment of cardiac masses. Echocardiography 24:286–300
Vallurupalli S, Hayes K, Bhatti S (2014) Ventricular papillary fibroelastoma. J Am Coll Cardiol 63:2170
Srivatsa SV, Adhikari P, Chaudhry P, Srivatsa SS (2013) Multimodality imaging of right-sided (tricuspid valve) papillary fibroelastoma: recognition of a surgically remediable disease. Case Rep Oncol 6:485–489
Kiaffas MG, Powell AJ, Geva T (2002) Magnetic resonance imaging evaluation of cardiac tumor characteristics in infants and children. Am J Cardiol 89:1229–1233
Karamitsos TD, Piechnik SK, Banypersad SM (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. J Am Coll Cardiol Imaging 6:488–497
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Caspar, T., El Ghannudi, S., Ohana, M. et al. Magnetic resonance evaluation of cardiac thrombi and masses by T1 and T2 mapping: an observational study. Int J Cardiovasc Imaging 33, 551–559 (2017). https://doi.org/10.1007/s10554-016-1034-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-016-1034-6